BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 23155247)

  • 1. Desensitization of NFκB for overcoming chemoresistance of pancreatic cancer cells to TNF-α or paclitaxel.
    Fujioka S; Son K; Onda S; Schmidt C; Scrabas GM; Okamoto T; Fujita T; Chiao PJ; Yanaga K
    Anticancer Res; 2012 Nov; 32(11):4813-21. PubMed ID: 23155247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
    Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
    Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function of nuclear factor kappaB in pancreatic cancer metastasis.
    Fujioka S; Sclabas GM; Schmidt C; Frederick WA; Dong QG; Abbruzzese JL; Evans DB; Baker C; Chiao PJ
    Clin Cancer Res; 2003 Jan; 9(1):346-54. PubMed ID: 12538487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus-mediated inhibition of NF-kappaB confers chemo-sensitization and apoptosis in prostate cancer cells.
    Flynn V; Ramanitharan A; Moparty K; Davis R; Sikka S; Agrawal KC; Abdel-Mageed AB
    Int J Oncol; 2003 Aug; 23(2):317-23. PubMed ID: 12851680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro.
    Bai J; Sui J; Demirjian A; Vollmer CM; Marasco W; Callery MP
    Cancer Res; 2005 Mar; 65(6):2344-52. PubMed ID: 15781649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.
    Sreekanth CN; Bava SV; Sreekumar E; Anto RJ
    Oncogene; 2011 Jul; 30(28):3139-52. PubMed ID: 21317920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-kappa B-mediated chemoresistance in breast cancer cells.
    Weldon CB; Burow ME; Rolfe KW; Clayton JL; Jaffe BM; Beckman BS
    Surgery; 2001 Aug; 130(2):143-50. PubMed ID: 11490342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gossypol decreases tumor necrosis factor-α-induced intercellular adhesion molecule-1 expression via suppression of NF-κB activity.
    Moon DO; Choi YH; Moon SK; Kim WJ; Kim GY
    Food Chem Toxicol; 2011 Apr; 49(4):999-1005. PubMed ID: 21223991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
    Tse AK; Wan CK; Shen XL; Yang M; Fong WF
    Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of TNF-alpha-induced apoptosis in corneal fibroblasts by transcription factor NF-kappaB.
    Mohan RR; Mohan RR; Kim WJ; Wilson SE
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1327-36. PubMed ID: 10798647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells.
    Ganta S; Amiji M
    Mol Pharm; 2009; 6(3):928-39. PubMed ID: 19278222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.
    Dong QG; Sclabas GM; Fujioka S; Schmidt C; Peng B; Wu T; Tsao MS; Evans DB; Abbruzzese JL; McDonnell TJ; Chiao PJ
    Oncogene; 2002 Sep; 21(42):6510-9. PubMed ID: 12226754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
    Huerta-Yepez S; Vega M; Garban H; Bonavida B
    Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxycycline induces apoptosis in PANC-1 pancreatic cancer cells.
    Son K; Fujioka S; Iida T; Furukawa K; Fujita T; Yamada H; Chiao PJ; Yanaga K
    Anticancer Res; 2009 Oct; 29(10):3995-4003. PubMed ID: 19846942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell death in response to antimetabolites directed at thymidylate synthase.
    Barbour KW; Berger FG
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):189-201. PubMed ID: 17396263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An essential role for nuclear factor kappa B in preventing TNF-alpha-induced cell death in prostate cancer cells.
    Sumitomo M; Tachibana M; Nakashima J; Murai M; Miyajima A; Kimura F; Hayakawa M; Nakamura H
    J Urol; 1999 Feb; 161(2):674-9. PubMed ID: 9915481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressed NF-kappaB and sustained JNK activation contribute to the sensitization effect of parthenolide to TNF-alpha-induced apoptosis in human cancer cells.
    Zhang S; Lin ZN; Yang CF; Shi X; Ong CN; Shen HM
    Carcinogenesis; 2004 Nov; 25(11):2191-9. PubMed ID: 15256485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation.
    Shigeno M; Nakao K; Ichikawa T; Suzuki K; Kawakami A; Abiru S; Miyazoe S; Nakagawa Y; Ishikawa H; Hamasaki K; Nakata K; Ishii N; Eguchi K
    Oncogene; 2003 Mar; 22(11):1653-62. PubMed ID: 12642868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid induction of apoptosis by combination of flavopiridol and tumor necrosis factor (TNF)-alpha or TNF-related apoptosis-inducing ligand in human cancer cell lines.
    Kim DM; Koo SY; Jeon K; Kim MH; Lee J; Hong CY; Jeong S
    Cancer Res; 2003 Feb; 63(3):621-6. PubMed ID: 12566305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sabarubicin- (MEN 10755) and paclitaxel show different kinetics in nuclear factor-kappaB (NF-kB) activation: effect of parthenolide on their cytotoxicity.
    Bellarosa D; Binaschi M; Maggi CA; Goso C
    Anticancer Res; 2005; 25(3B):2119-28. PubMed ID: 16158953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.